Renovorx, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Renovorx, Inc. (RNXT) on June 9, 2023, regarding events occurring on June 8, 2023. The filing details the results of the Company's Annual Meeting of Stockholders. Renovorx is an emerging growth company incorporated in Delaware with principal executive offices in Los Altos, California.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes
The primary material event reported is the completion of the Annual Meeting of Stockholders. Key outcomes include:
- Election of Directors: All seven director nominees were duly elected to serve until the 2024 Annual Meeting.
- Accounting Firm Ratification: Stockholders ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the voting results of the Annual Meeting.
Key Facts for Investor Verification
- Voting Results: Verify the specific vote counts for each director nominee, noting that "Broker Non-Votes" were recorded for all director elections (2,374,191 shares).
- Accounting Firm: Confirm that Baker Tilly US, LLP is the appointed auditor for the fiscal year ending December 31, 2023.
- Board Composition: Note the successful election of the full slate of directors, including Ramtin Agah, M.D., Shaun R. Bagai, David Diamond, Kirsten Angela Macfarlane, Laurence J. Marton, M.D., Una S. Ryan, O.B.E., Ph.D., D.Sc., and Robert J. Spiegel, M.D., FACP.
- Shareholder Support: Observe the high level of support for Proposal 2 (Ratification of Auditor), with 7,463,474 votes "For" versus 22,982 "Against."